Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study

Abstract One of the major pathomechanisms of COVID-19 is the interplay of hyperinflammation and disruptions in coagulation processes, involving thrombocytes. Antiplatelet therapy (AP) by anti-inflammatory effect and inhibition of platelet aggregation may affect these pathways. The aim of this study...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Scientific Reports
المؤلفون الرئيسيون:	Mateusz Sokolski, Konrad Reszka, Barbara Adamik, Katarzyna Kilis-Pstrusinska, Weronika Lis, Michał Pomorski, Janusz Sokolowski, Adrian Doroszko, Katarzyna Madziarska, Ewa Anita Jankowska, Marcin Protasiewicz
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Nature Portfolio 2024-02-01
الوصول للمادة أونلاين:	https://doi.org/10.1038/s41598-024-55407-9